Literature DB >> 21190393

Senataxin mutations and amyotrophic lateral sclerosis.

Michio Hirano1, Catarina M Quinzii, Hiroshi Mitsumoto, Arthur P Hays, J Kirk Roberts, Patricia Richard, Lewis P Rowland.   

Abstract

We studied three patients with mutations in the senataxin gene (SETX). One had juvenile onset of ALS. The second case resembled hereditary motor neuropathy. The third patient had an overlap syndrome of ataxia-tremor and motor neuron disease, phenotypes previously associated with SETX mutations. Our patients were all apparently sporadic, with no other affected relative. Two relatives of patient no. 2 carried the SETX c.4660T > G transversion but did not manifest motor neuron disease, abnormal eye movements, ataxia, or tremor suggesting that genetic or environmental modifiers may influence expression of this SETX polymorphism. Relatives of patients 1 and 3 were not available for examination or SETX mutation screening. Mutations causing ALS4 may be more frequent and heterogeneous than expected. Screening for SETX mutations should be considered in patients with apparently sporadic juvenile-onset ALS, hereditary motor neuropathy, and overlap syndromes with ataxia and motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190393      PMCID: PMC7528023          DOI: 10.3109/17482968.2010.545952

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  24 in total

1.  NERVE CONDUCTION AND OTHER STUDIES IN FAMILIES WITH CHARCOT-MARIE-TOOTH DISEASE.

Authors:  N C MYRIANTHOPOULOS; M H LANE; D H SILBERBERG; B L VINCENT
Journal:  Brain       Date:  1964-12       Impact factor: 13.501

2.  Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives.

Authors:  Ana Beleza-Meireles; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler       Date:  2009-02

3.  Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34.

Authors:  P F Chance; B A Rabin; S G Ryan; Y Ding; M Scavina; B Crain; J W Griffin; D R Cornblath
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 4.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics.

Authors:  Piera Pasinelli; Robert H Brown
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

5.  Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity.

Authors:  T Siddique; D A Figlewicz; M A Pericak-Vance; J L Haines; G Rouleau; A J Jeffers; P Sapp; W Y Hung; J Bebout; D McKenna-Yasek
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

6.  A novel mutation in the senataxin gene identified in a Chinese patient with sporadic amyotrophic lateral sclerosis.

Authors:  Zhen-hua Zhao; Wen-Zu Chen; Zhi-ying Wu; Ning Wang; Gui-xian Zhao; Wan-jin Chen; Shen-xing Murong
Journal:  Amyotroph Lateral Scler       Date:  2009-04

Review 7.  RNA processing defects associated with diseases of the motor neuron.

Authors:  Stephen J Kolb; Scott Sutton; Daniel R Schoenberg
Journal:  Muscle Nerve       Date:  2010-01       Impact factor: 3.217

8.  Ataxia oculomotor apraxia type 2: course over 27 years and a novel stop mutation in the senataxin gene.

Authors:  Tobias Haack; Douglas Friday; Andreas Bender; Arndt Rolfs; Thomas Klopstock
Journal:  J Neurol       Date:  2009-04-18       Impact factor: 4.849

Review 9.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms.

Authors:  Patrick A Dion; Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2009-10-13       Impact factor: 53.242

10.  Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy.

Authors:  M Ben Hamida; F Hentati; C Ben Hamida
Journal:  Brain       Date:  1990-04       Impact factor: 13.501

View more
  34 in total

Review 1.  Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.

Authors:  Seth A Bennett; Royena Tanaz; Samantha N Cobos; Mariana P Torrente
Journal:  Transl Res       Date:  2018-10-12       Impact factor: 7.012

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 3.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

4.  Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression.

Authors:  Zhang-Yu Zou; Ming-Sheng Liu; Xiao-Guang Li; Li-Ying Cui
Journal:  Ann Transl Med       Date:  2015-09

Review 5.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 6.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

Review 7.  Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.

Authors:  Diane Moujalled; Anthony R White
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

Review 8.  R Loops and Links to Human Disease.

Authors:  Patricia Richard; James L Manley
Journal:  J Mol Biol       Date:  2016-09-04       Impact factor: 5.469

Review 9.  Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.

Authors:  Lavinia C Dumitrache; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2016-04-26       Impact factor: 5.432

10.  The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases.

Authors:  Larissa Arning; Jörg T Epplen; Elisa Rahikkala; Corinna Hendrich; Albert C Ludolph; Anne-Dorte Sperfeld
Journal:  Neurogenetics       Date:  2012-11-06       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.